SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0482
0.00 (0.00%)
Apr 19, 2024, 4:00 PM EDT - Market closed

SQZB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
21.4827.12120.1112.67
Revenue Growth (YoY)
-20.74%29.05%4.42%58.73%-
Gross Profit
21.4827.12120.1112.67
Selling, General & Admin
26.3225.7220.5118.278.69
Research & Development
70.9870.1551.5536.124.38
Other Operating Expenses
4.860000
Operating Expenses
102.1695.8772.0654.3733.07
Operating Income
-80.68-68.77-51.06-34.27-20.4
Interest Expense / Income
00000.06
Other Expense / Income
-1.22-0.03-0.54-2.06-1.21
Pretax Income
-79.46-68.74-50.52-32.2-19.25
Net Income
-79.46-68.74-50.52-32.2-19.25
Preferred Dividends
00000.98
Net Income Common
-79.46-68.74-50.52-32.2-20.23
Shares Outstanding (Basic)
2928522
Shares Outstanding (Diluted)
2928522
Shares Change
4.47%410.54%216.92%7.43%-
EPS (Basic)
-2.76-2.49-9.35-18.89-12.75
EPS (Diluted)
-2.76-2.49-9.35-18.89-12.75
Free Cash Flow
-84.04-82.75-44.33-35.6619.79
Free Cash Flow Per Share
-2.92-3.00-8.21-20.9212.47
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-375.66%-253.78%-243.16%-170.40%-161.05%
Profit Margin
-369.98%-253.68%-240.60%-160.14%-159.71%
Free Cash Flow Margin
-391.27%-305.37%-211.11%-177.33%156.22%
EBITDA
-67.78-57.71-39.58-27.85-18.12
EBITDA Margin
-315.58%-212.97%-188.48%-138.48%-143.06%
Depreciation & Amortization
11.6811.0310.944.361.07
EBIT
-79.46-68.74-50.52-32.2-19.19
EBIT Margin
-369.98%-253.68%-240.60%-160.14%-151.48%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).